Clinical Trial Update: Pazopanib in Treating Patients With Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial update of pazopanib for recurrent glioblastoma; results have been posted following study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15